![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Adis International Limited
Publisher: Adis International
ISSN: 1172-0360
Source: Drugs & Therapy Perspectives, Vol.21, Iss.2, 2005-02, pp. : 1-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Extended-release oxybutynin an effective option in overactive bladder
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tolterodine effective in the treatment of overactive bladder
Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Extended-release ciprofloxacin a more convenient option for UTIs
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :